Collection
Advances in Personalized Therapy for Patients with Colorectal Cancer
Colorectal cancer is a major cause of cancer-related morbidity and mortality worldwide. There is growing interest in developing personalized approaches to multidisciplinary cancer care that take into consideration an individual cancer’s unique clinical, biological, genetic, radiographic, and other characteristics. In this special article for the Journal of Gastrointestinal Cancer, we highlight several timely review and original research articles on advances in personalized therapy for colorectal cancer.
Articles (10 in this collection)
-
-
A Review of Circulating Tumor DNA as a Biomarker Guide for Total Neoadjuvant Therapy in Patients with Locally Advanced Rectal Cancer
Authors (first, second and last of 5)
-
-
A Cost-effectiveness Analysis of Adding Cetuximab to the First-line Treatment of Metastatic Colorectal Carcinoma in Iran; Considering Genetic Screening for Precision Medicine
Authors (first, second and last of 5)
-
Multi-Disciplinary Management in Rectal Cancer Survivorship: A Clinical Practice Review
Authors (first, second and last of 10)
-
Variations in the Type of Adjuvant Chemotherapy Among Stage III Colon Cancer Patients in England
Authors (first, second and last of 4)
-
Contemporary Outcomes for the Curative Treatment of Colorectal Cancer Pulmonary Metastases
Authors (first, second and last of 9)
-
-
Utilizing Patient-Derived Organoids in the Management of Colorectal Cancer with Peritoneal Metastases: A Review of Current Literature
Authors (first, second and last of 7)
-
